TRDA ▼ -0.8% - Entrada Therapeutics, Inc.
$TRDA - Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
18-NOV-2026 03:00 AM ET
Share this post
More filings for $TRDA
TRDA ▼ -0.2% - Entrada Therapeutics, Inc.Nov 5, 2026TRDA ▲ +0.4% - Entrada Therapeutics, Inc.Oct 21, 2026TRDA ▲ +3.5% - Entrada Therapeutics, Inc.Oct 14, 2026TRDA ▲ +3.5% - Entrada Therapeutics, Inc.Oct 14, 2026TRDA - Entrada Therapeutics, Inc. - SEC Filing Update (10-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 10, 2026TRDA ▲ +1.4% - Entrada Therapeutics, Inc.Sep 10, 2026
View full $TRDA filing history →💬 Comments
Loading comments…
Leave a comment
